{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:46:12Z","timestamp":1790894772873,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The androgen receptor (AR) plays critical roles in both androgen-dependent and castrate-resistant prostate cancer (PCa). However, little is known about AR target genes that mediate the receptor's roles in disease progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Using Chromatin Immunoprecipitation (ChIP) Display, we discovered 19 novel loci occupied by the AR in castrate resistant C4-2B PCa cells. Only four of the 19 AR-occupied regions were within 10-kb 5'-flanking regulatory sequences. Three were located up to 4-kb 3' of the nearest gene, eight were intragenic and four were in gene deserts. Whereas the AR occupied the same loci in C4-2B (castrate resistant) and LNCaP (androgen-dependent) PCa cells, differences between the two cell lines were observed in the response of nearby genes to androgens. Among the genes strongly stimulated by DHT in C4-2B cells \u2013 D-dopachrome tautomerase (DDT), Protein kinase C delta (PRKCD), Glutathione S- transferase theta 2 (GSTT2), Transient receptor potential cation channel subfamily V member 3 (TRPV3), and Pyrroline-5-carboxylate reductase 1 (PYCR1) \u2013 most were less strongly or hardly stimulated in LNCaP cells. Another AR target gene, ornithine aminotransferase (OAT), was AR-stimulated in a ligand-independent manner, since it was repressed by AR siRNA knockdown, but not stimulated by DHT. We also present evidence for <jats:italic>in vivo<\/jats:italic> AR-mediated regulation of several genes identified by ChIP Display. For example, PRKCD and PYCR1, which may contribute to PCa cell growth and survival, are expressed in PCa biopsies from primary tumors before and after ablation and in metastatic lesions in a manner consistent with AR-mediated stimulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>AR genomic occupancy is similar between LNCaP and C4-2B cells and is not biased towards 5' gene flanking sequences. The AR transcriptionally regulates less than half the genes nearby AR-occupied regions, usually but not always, in a ligand-dependent manner. Most are stimulated and a few are repressed. In general, response is stronger in C4-2B compared to LNCaP cells. Some of the genes near AR-occupied regions appear to be regulated by the AR <jats:italic>in vivo<\/jats:italic> as evidenced by their expression levels in prostate cancer tumors of various stages. Several AR target genes discovered in the present study, for example PRKCD and PYCR1, may open avenues in PCa research and aid the development of new approaches for disease management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-6-39","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T06:13:26Z","timestamp":1181196806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Identification of novel androgen receptor target genes in prostate cancer"],"prefix":"10.1186","volume":"6","author":[{"given":"Unnati","family":"Jariwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Barski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Pregizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon P","family":"Cogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Arasheben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne D","family":"Tilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard I","family":"Scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L","family":"Gerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard A","family":"Coetzee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baruch","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,6]]},"reference":[{"key":"247_CR1","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2741\/1891","volume":"11","author":"AW Hsing","year":"2006","unstructured":"Hsing AW, Chokkalingam AP: Prostate cancer epidemiology. Front Biosci. 2006, 11: 1388-1413. 10.2741\/1891","journal-title":"Front Biosci"},{"issue":"2","key":"247_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0012-1606(02)00031-3","volume":"253","author":"PC Marker","year":"2003","unstructured":"Marker PC, Donjacour AA, Dahiya R, Cunha GR: Hormonal, cellular, and molecular control of prostatic development. Dev Biol. 2003, 253 (2): 165-174. 10.1016\/S0012-1606(02)00031-3","journal-title":"Dev Biol"},{"issue":"2","key":"247_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J","volume":"28","author":"H Bonkhoff","year":"1996","unstructured":"Bonkhoff H, Remberger K: Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate. 1996, 28 (2): 98-106. 10.1002\/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J","journal-title":"Prostate"},{"issue":"4\u20136","key":"247_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0960-0760(97)00122-2","volume":"63","author":"P Geck","year":"1997","unstructured":"Geck P, Szelei J, Jimenez J, Lin TM, Sonnenschein C, Soto AM: Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells. J Steroid Biochem Mol Biol. 1997, 63 (4\u20136): 211-218. 10.1016\/S0960-0760(97)00122-2","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"247_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1677\/erc.1.00525","volume":"11","author":"HI Scher","year":"2004","unstructured":"Scher HI, Buchanan G, Gerald W, Butler LM, Tilley WD: Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocr Relat Cancer. 2004, 11 (3): 459-476. 10.1677\/erc.1.00525","journal-title":"Endocr Relat Cancer"},{"issue":"3 Suppl 1","key":"247_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0090-4295(02)01593-5","volume":"60","author":"SP Balk","year":"2002","unstructured":"Balk SP: Androgen receptor as a target in androgen-independent prostate cancer. Urology. 2002, 60 (3 Suppl 1): 132-138. discussion 138\u2013139., 10.1016\/S0090-4295(02)01593-5","journal-title":"Urology"},{"issue":"3\u20134","key":"247_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1023\/A:1015531326689","volume":"20","author":"G Buchanan","year":"2001","unstructured":"Buchanan G, Irvine RA, Coetzee GA, Tilley WD: Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev. 2001, 20 (3\u20134): 207-223. 10.1023\/A:1015531326689","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"247_CR8","first-page":"1008","volume":"62","author":"OL Zegarra-Moro","year":"2002","unstructured":"Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ: Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res. 2002, 62 (4): 1008-1013.","journal-title":"Cancer Res"},{"issue":"1","key":"247_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nm972","volume":"10","author":"CD Chen","year":"2004","unstructured":"Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL: Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2004, 10 (1): 33-39. 10.1038\/nm972","journal-title":"Nat Med"},{"issue":"4","key":"247_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1073\/pnas.0408925102","volume":"102","author":"G Han","year":"2005","unstructured":"Han G, Buchanan G, Ittmann M, Harris JM, Yu X, Demayo FJ, Tilley W, Greenberg NM: Mutation of the androgen receptor causes oncogenic transformation of the prostate. Proc Natl Acad Sci USA. 2005, 102 (4): 1151-1156. 10.1073\/pnas.0408925102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"247_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nrc1474","volume":"4","author":"CA Borgono","year":"2004","unstructured":"Borgono CA, Diamandis EP: The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004, 4 (11): 876-890. 10.1038\/nrc1474","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"247_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1515\/BC.2006.089","volume":"387","author":"AK Whitbread","year":"2006","unstructured":"Whitbread AK, Veveris-Lowe TL, Lawrence MG, Nicol DL, Clements JA: The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition. Biol Chem. 2006, 387 (6): 707-714. 10.1515\/BC.2006.089","journal-title":"Biol Chem"},{"issue":"33","key":"247_CR13","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/sj.onc.1205663","volume":"21","author":"VJ Gnanapragasam","year":"2002","unstructured":"Gnanapragasam VJ, Robson CN, Neal DE, Leung HY: Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene. 2002, 21 (33): 5069-5080. 10.1038\/sj.onc.1205663","journal-title":"Oncogene"},{"issue":"24","key":"247_CR14","first-page":"5718","volume":"58","author":"CW Gregory","year":"1998","unstructured":"Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS: Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res. 1998, 58 (24): 5718-5724.","journal-title":"Cancer Res"},{"issue":"15","key":"247_CR15","first-page":"4299","volume":"63","author":"LL Xu","year":"2003","unstructured":"Xu LL, Shi Y, Petrovics G, Sun C, Makarem M, Zhang W, Sesterhenn IA, McLeod DG, Sun L, Moul JW: PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Cancer Res. 2003, 63 (15): 4299-4304.","journal-title":"Cancer Res"},{"issue":"17","key":"247_CR16","first-page":"4180","volume":"59","author":"B Lin","year":"1999","unstructured":"Lin B, Ferguson C, White JT, Wang S, Vessella R, True LD, Hood L, Nelson PS: Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res. 1999, 59 (17): 4180-4184.","journal-title":"Cancer Res"},{"issue":"7","key":"247_CR17","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-06-0168","volume":"66","author":"SA Tomlins","year":"2006","unstructured":"Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB: TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res. 2006, 66 (7): 3396-3400. 10.1158\/0008-5472.CAN-06-0168","journal-title":"Cancer Res"},{"issue":"5748","key":"247_CR18","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005, 310 (5748): 644-648. 10.1126\/science.1117679","journal-title":"Science"},{"issue":"12","key":"247_CR19","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1093\/nar\/gnh097","volume":"32","author":"A Barski","year":"2004","unstructured":"Barski A, Frenkel B: ChIP Display: novel method for identification of genomic targets of transcription factors. Nucleic Acids Res. 2004, 32 (12): e104- 10.1093\/nar\/gnh097","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"247_CR20","first-page":"2577","volume":"54","author":"GN Thalmann","year":"1994","unstructured":"Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW: Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res. 1994, 54 (10): 2577-2581.","journal-title":"Cancer Res"},{"key":"247_CR21","volume-title":"The Prostate","author":"J Prescott","year":"2007","unstructured":"Prescott J, Jariwala U, Jia L, Cogan JP, Barski A, Pregizer S, Arasheben A, Neilson JJ, Frenkel B, Coetzee GA: Androgen Receptor-Mediated Repression of Novel Target Genes. The Prostate. 2007, ,"},{"issue":"19","key":"247_CR22","doi-asserted-by":"publisher","first-page":"7331","DOI":"10.1128\/MCB.00581-06","volume":"26","author":"L Jia","year":"2006","unstructured":"Jia L, Shen HC, Wantroba M, Khalid O, Liang G, Wang Q, Gentzschein E, Pinski JK, Stanczyk FZ, Jones PA: Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol. 2006, 26 (19): 7331-7341. 10.1128\/MCB.00581-06","journal-title":"Mol Cell Biol"},{"issue":"5","key":"247_CR23","first-page":"385","volume":"1","author":"L Jia","year":"2003","unstructured":"Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA: Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Mol Cancer Res. 2003, 1 (5): 385-392.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"247_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0002-9440(10)63112-4","volume":"164","author":"J Holzbeierlein","year":"2004","unstructured":"Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol. 2004, 164 (1): 217-227.","journal-title":"Am J Pathol"},{"issue":"32","key":"247_CR25","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.1200\/JCO.2005.03.4777","volume":"23","author":"HI Scher","year":"2005","unstructured":"Scher HI, Sawyers CL: Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol. 2005, 23 (32): 8253-8261. 10.1200\/JCO.2005.03.4777","journal-title":"J Clin Oncol"},{"issue":"1","key":"247_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1210\/me.7.1.23","volume":"7","author":"PS Rennie","year":"1993","unstructured":"Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS: Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol. 1993, 7 (1): 23-36. 10.1210\/me.7.1.23","journal-title":"Mol Endocrinol"},{"issue":"25","key":"247_CR27","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1021\/bi00076a020","volume":"32","author":"P Murtha","year":"1993","unstructured":"Murtha P, Tindall DJ, Young CY: Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. Biochemistry. 1993, 32 (25): 6459-6464. 10.1021\/bi00076a020","journal-title":"Biochemistry"},{"issue":"12","key":"247_CR28","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1210\/mend-5-12-1921","volume":"5","author":"PH Riegman","year":"1991","unstructured":"Riegman PH, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J: The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol. 1991, 5 (12): 1921-1930.","journal-title":"Mol Endocrinol"},{"issue":"11","key":"247_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/ng1901","volume":"38","author":"JS Carroll","year":"2006","unstructured":"Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF: Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006, 38 (11): 1289-1297. 10.1038\/ng1901","journal-title":"Nat Genet"},{"issue":"1","key":"247_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cell.2005.10.043","volume":"124","author":"CL Wei","year":"2006","unstructured":"Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z: A global map of p53 transcription-factor binding sites in the human genome. Cell. 2006, 124 (1): 207-219. 10.1016\/j.cell.2005.10.043","journal-title":"Cell"},{"issue":"5","key":"247_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molcel.2005.07.018","volume":"19","author":"Q Wang","year":"2005","unstructured":"Wang Q, Carroll JS, Brown M: Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell. 2005, 19 (5): 631-642. 10.1016\/j.molcel.2005.07.018","journal-title":"Mol Cell"},{"issue":"7042","key":"247_CR32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature03574","volume":"435","author":"CG Spilianakis","year":"2005","unstructured":"Spilianakis CG, Lalioti MD, Town T, Lee GR, Flavell RA: Interchromosomal associations between alternatively expressed loci. Nature. 2005, 435 (7042): 637-645. 10.1038\/nature03574","journal-title":"Nature"},{"issue":"7","key":"247_CR33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2006.06.009","volume":"125","author":"AT Willingham","year":"2006","unstructured":"Willingham AT, Gingeras TR: TUF love for \"junk\" DNA. Cell. 2006, 125 (7): 1215-1220. 10.1016\/j.cell.2006.06.009","journal-title":"Cell"},{"issue":"18","key":"247_CR34","doi-asserted-by":"publisher","first-page":"11890","DOI":"10.1073\/pnas.182376299","volume":"99","author":"PS Nelson","year":"2002","unstructured":"Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B: The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA. 2002, 99 (18): 11890-11895. 10.1073\/pnas.182376299","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"247_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ijc.1196","volume":"92","author":"LL Xu","year":"2001","unstructured":"Xu LL, Su YP, Labiche R, Segawa T, Shanmugam N, McLeod DG, Moul JW, Srivastava S: Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes. Int J Cancer. 2001, 92 (3): 322-328. 10.1002\/ijc.1196","journal-title":"Int J Cancer"},{"issue":"6","key":"247_CR36","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/S0002-9440(10)61165-0","volume":"160","author":"T Ernst","year":"2002","unstructured":"Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klaren R, Grone EF, Wiesel M, Gudemann C: Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol. 2002, 160 (6): 2169-2180.","journal-title":"Am J Pathol"},{"issue":"4","key":"247_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0092-8674(04)00127-8","volume":"116","author":"S Cawley","year":"2004","unstructured":"Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ: Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell. 2004, 116 (4): 499-509. 10.1016\/S0092-8674(04)00127-8","journal-title":"Cell"},{"key":"247_CR38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0076-6879(02)50979-4","volume":"350","author":"CE Horak","year":"2002","unstructured":"Horak CE, Snyder M: ChIP-chip: a genomic approach for identifying transcription factor binding sites. Methods Enzymol. 2002, 350: 469-483.","journal-title":"Methods Enzymol"},{"issue":"5500","key":"247_CR39","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1126\/science.290.5500.2306","volume":"290","author":"B Ren","year":"2000","unstructured":"Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, Simon I, Zeitlinger J, Schreiber J, Hannett N, Kanin E: Genome-wide location and function of DNA binding proteins. Science. 2000, 290 (5500): 2306-2309. 10.1126\/science.290.5500.2306","journal-title":"Science"},{"issue":"13","key":"247_CR40","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1073\/pnas.0407069102","volume":"102","author":"J Chen","year":"2005","unstructured":"Chen J, Sadowski I: Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc Natl Acad Sci USA. 2005, 102 (13): 4813-4818. 10.1073\/pnas.0407069102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"247_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nmeth726","volume":"2","author":"J Kim","year":"2005","unstructured":"Kim J, Bhinge AA, Morgan XC, Iyer VR: Mapping DNA-protein interactions in large genomes by sequence tag analysis of genomic enrichment. Nat Methods. 2005, 2 (1): 47-53. 10.1038\/nmeth726","journal-title":"Nat Methods"},{"issue":"8","key":"247_CR42","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nbt990","volume":"22","author":"TY Roh","year":"2004","unstructured":"Roh TY, Ngau WC, Cui K, Landsman D, Zhao K: High-resolution genome-wide mapping of histone modifications. Nat Biotechnol. 2004, 22 (8): 1013-1016. 10.1038\/nbt990","journal-title":"Nat Biotechnol"},{"issue":"7","key":"247_CR43","first-page":"1041","volume":"119","author":"S Impey","year":"2004","unstructured":"Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, Boss JM, McWeeney S, Dunn JJ, Mandel G, Goodman RH: Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell. 2004, 119 (7): 1041-1054.","journal-title":"Cell"},{"issue":"4","key":"247_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/74487","volume":"18","author":"B van Steensel","year":"2000","unstructured":"van Steensel B, Henikoff S: Identification of in vivo DNA targets of chromatin proteins using tethered dam methyltransferase. Nat Biotechnol. 2000, 18 (4): 424-428. 10.1038\/74487","journal-title":"Nat Biotechnol"},{"issue":"3\u20134","key":"247_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jsbmb.2005.04.029","volume":"96","author":"P Haag","year":"2005","unstructured":"Haag P, Bektic J, Bartsch G, Klocker H, Eder IE: Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol. 2005, 96 (3\u20134): 251-258. 10.1016\/j.jsbmb.2005.04.029","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"247_CR46","first-page":"652","volume":"104","author":"HC Chang","year":"2005","unstructured":"Chang HC, Chen SC, Chen J, Hsieh JT: In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line. J Formos Med Assoc. 2005, 104 (9): 652-658.","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"247_CR47","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0002-9440(10)64422-7","volume":"161","author":"P Li","year":"2002","unstructured":"Li P, Yu X, Ge K, Melamed J, Roeder RG, Wang Z: Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol. 2002, 161 (4): 1467-1474.","journal-title":"Am J Pathol"},{"issue":"1","key":"247_CR48","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1210\/en.2005-1001","volume":"147","author":"JA Magee","year":"2006","unstructured":"Magee JA, Chang LW, Stormo GD, Milbrandt J: Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology. 2006, 147 (1): 590-598. 10.1210\/en.2005-1001","journal-title":"Endocrinology"},{"issue":"24","key":"247_CR49","doi-asserted-by":"publisher","first-page":"13009","DOI":"10.1073\/pnas.230445997","volume":"97","author":"SA Maxwell","year":"2000","unstructured":"Maxwell SA, Davis GE: Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc Natl Acad Sci USA. 2000, 97 (24): 13009-13014. 10.1073\/pnas.230445997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"247_CR50","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1073\/pnas.0407960102","volume":"102","author":"C Chen","year":"2005","unstructured":"Chen C, Dickman MB: Proline suppresses apoptosis in the fungal pathogen Colletotrichum trifolii. Proc Natl Acad Sci USA. 2005, 102 (9): 3459-3464. 10.1073\/pnas.0407960102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"247_CR51","first-page":"3230","volume":"59","author":"SC Kiley","year":"1999","unstructured":"Kiley SC, Clark KJ, Goodnough M, Welch DR, Jaken S: Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res. 1999, 59 (13): 3230-3238.","journal-title":"Cancer Res"},{"issue":"3","key":"247_CR52","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.bbrc.2006.03.044","volume":"343","author":"S Kharait","year":"2006","unstructured":"Kharait S, Dhir R, Lauffenburger D, Wells A: Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochem Biophys Res Commun. 2006, 343 (3): 848-856.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"247_CR53","doi-asserted-by":"publisher","first-page":"7574","DOI":"10.1074\/jbc.275.11.7574","volume":"275","author":"T Fujii","year":"2000","unstructured":"Fujii T, Garcia-Bermejo ML, Bernabo JL, Caamano J, Ohba M, Kuroki T, Li L, Yuspa SH, Kazanietz MG: Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. J Biol Chem. 2000, 275 (11): 7574-7582. 10.1074\/jbc.275.11.7574","journal-title":"J Biol Chem"},{"issue":"6","key":"247_CR54","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1172\/JCI0214146","volume":"109","author":"M Sumitomo","year":"2002","unstructured":"Sumitomo M, Ohba M, Asakuma J, Asano T, Kuroki T, Asano T, Hayakawa M: Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J Clin Invest. 2002, 109 (6): 827-836. 10.1172\/JCI200214146","journal-title":"J Clin Invest"},{"issue":"36","key":"247_CR55","doi-asserted-by":"publisher","first-page":"33753","DOI":"10.1074\/jbc.M303313200","volume":"278","author":"Y Tanaka","year":"2003","unstructured":"Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, Kazanietz MG: Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J Biol Chem. 2003, 278 (36): 33753-33762. 10.1074\/jbc.M303313200","journal-title":"J Biol Chem"},{"issue":"6","key":"247_CR56","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/j.1471-4159.2005.03473.x","volume":"95","author":"JA Ortiz","year":"2005","unstructured":"Ortiz JA, Castillo M, del Toro ED, Mulet J, Gerber S, Valor LM, Sala S, Sala F, Gutierrez LM, Criado M: The cysteine-rich with EGF-like domains 2 (CRELD2) protein interacts with the large cytoplasmic domain of human neuronal nicotinic acetylcholine receptor alpha4 and beta2 subunits. J Neurochem. 2005, 95 (6): 1585-1596. 10.1111\/j.1471-4159.2005.03473.x","journal-title":"J Neurochem"},{"issue":"2","key":"247_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1006\/bbrc.1998.8123","volume":"243","author":"J Nishihira","year":"1998","unstructured":"Nishihira J, Fujinaga M, Kuriyama T, Suzuki M, Sugimoto H, Nakagawa A, Tanaka I, Sakai M: Molecular cloning of human D-dopachrome tautomerase cDNA: N-terminal proline is essential for enzyme activation. Biochem Biophys Res Commun. 1998, 243 (2): 538-544. 10.1006\/bbrc.1998.8123","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"247_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth MA, Swanson BJ: Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004, 4 (1): 45-60. 10.1038\/nrc1251","journal-title":"Nat Rev Cancer"},{"issue":"5560","key":"247_CR59","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1126\/science.1069094","volume":"295","author":"A Velcich","year":"2002","unstructured":"Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K, Augenlicht L: Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002, 295 (5560): 1726-1729. 10.1126\/science.1069094","journal-title":"Science"},{"issue":"2","key":"247_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ceca.2005.10.006","volume":"39","author":"EC Schwarz","year":"2006","unstructured":"Schwarz EC, Wissenbach U, Niemeyer BA, Strauss B, Philipp SE, Flockerzi V, Hoth M: TRPV6 potentiates calcium-dependent cell proliferation. Cell Calcium. 2006, 39 (2): 163-173. 10.1016\/j.ceca.2005.10.006","journal-title":"Cell Calcium"},{"issue":"49","key":"247_CR61","doi-asserted-by":"publisher","first-page":"7858","DOI":"10.1038\/sj.onc.1206895","volume":"22","author":"T Fixemer","year":"2003","unstructured":"Fixemer T, Wissenbach U, Flockerzi V, Bonkhoff H: Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene. 2003, 22 (49): 7858-7861. 10.1038\/sj.onc.1206895","journal-title":"Oncogene"},{"issue":"6","key":"247_CR62","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/10409239509083491","volume":"30","author":"JD Hayes","year":"1995","unstructured":"Hayes JD, Pulford DJ: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995, 30 (6): 445-600.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"4","key":"247_CR63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s004390100488","volume":"108","author":"J Xu","year":"2001","unstructured":"Xu J, Zheng SL, Chang B, Smith JR, Carpten JD, Stine OC, Isaacs SD, Wiley KE, Henning L, Ewing C: Linkage of prostate cancer susceptibility loci to chromosome 1. Hum Genet. 2001, 108 (4): 335-345. 10.1007\/s004390100488","journal-title":"Hum Genet"},{"issue":"38","key":"247_CR64","doi-asserted-by":"publisher","first-page":"14068","DOI":"10.1073\/pnas.0605832103","volume":"103","author":"ML Freedman","year":"2006","unstructured":"Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM: Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA. 2006, 103 (38): 14068-14073. 10.1073\/pnas.0605832103","journal-title":"Proc Natl Acad Sci USA"},{"key":"247_CR65","unstructured":"Ensembl: [http:\/\/www.ensembl.org]"},{"key":"247_CR66","unstructured":"Consite: [http:\/\/www.phylofoot.org\/consite]"},{"issue":"15","key":"247_CR67","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1158\/0008-5472.CAN-05-1948","volume":"65","author":"X Ouyang","year":"2005","unstructured":"Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C: Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res. 2005, 65 (15): 6773-6779. 10.1158\/0008-5472.CAN-05-1948","journal-title":"Cancer Res"},{"issue":"3","key":"247_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/gcc.10283","volume":"38","author":"M Yamaguchi","year":"2003","unstructured":"Yamaguchi M, Yamamoto K, Miura O: Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis. Genes Chromosomes Cancer. 2003, 38 (3): 269-273. 10.1002\/gcc.10283","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"247_CR69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2005.06.004","volume":"237","author":"M Verras","year":"2006","unstructured":"Verras M, Sun Z: Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett. 2006, 237 (1): 22-32. 10.1016\/j.canlet.2005.06.004","journal-title":"Cancer Lett"},{"key":"247_CR70","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1471-2407-6-186","volume":"6","author":"KJ Hewitt","year":"2006","unstructured":"Hewitt KJ, Agarwal R, Morin PJ: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 2006, 6: 186- 10.1186\/1471-2407-6-186","journal-title":"BMC Cancer"},{"issue":"8","key":"247_CR71","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.bjc.6603384","volume":"95","author":"N Ashraf","year":"2006","unstructured":"Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD, Shiels PG: Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer. 2006, 95 (8): 1056-1061. 10.1038\/sj.bjc.6603384","journal-title":"Br J Cancer"},{"issue":"10","key":"247_CR72","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/emboj\/21.10.2383","volume":"21","author":"E Langley","year":"2002","unstructured":"Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T: Human SIR2 deacetylates p53 and antagonizes PML\/p53-induced cellular senescence. Embo J. 2002, 21 (10): 2383-2396. 10.1093\/emboj\/21.10.2383","journal-title":"Embo J"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-6-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:18:56Z","timestamp":1630451936000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-6-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,6]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-6-39","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,6]]},"assertion":[{"value":"13 March 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}